Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed carbonylation method offers high yield and mild conditions for producing critical fluorinated heterocyclic building blocks.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazol-3-ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111777564B details a green aqueous photocatalytic method for quinazolinones using KI, offering cost-effective and scalable production for pharmaceutical intermediates.
Novel sulfur-promoted method for high-purity triazole intermediates. Cost-effective metal-free process ensuring supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN115353511A discloses a safe, multi-component palladium-catalyzed method for synthesizing carbonyl-bridged biheterocycles using in-situ carbon monoxide generation.
Patent CN111423381B reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply and cost efficiency.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers metal-free efficiency and scalable production for global API manufacturers.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for quinazolinone synthesis, offering significant supply chain advantages for pharmaceutical manufacturers.
Patent CN115925692A details Rh-catalyzed C-H activation for trifluoromethyl enamines. High yields, scalable process for drug discovery.
Patent CN102516300A discloses efficient phosphine ligands enabling superior enantioselectivity and simplified synthesis for cost-effective pharmaceutical intermediate manufacturing.
Novel patent CN118126005B details metal-free synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain reliability for global pharmaceutical manufacturing partners.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline intermediates. Catalyst-free process ensures cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Patent CN111423381A reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN118619879A reveals a Rh-catalyzed route for trifluoromethyl enaminones. This method offers high purity, scalability, and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Novel Pd-catalyzed serial cyclization for beta-halopyrroles. High purity, scalable process for pharma intermediates. Cost-effective supply chain solution.
Patent CN113429349A details a Cu/g-C3N4 catalyzed route for high-purity benzimidazoles, offering scalable production and cost-effective manufacturing solutions.
Novel Pd-catalyzed C-H activation method for 2-perfluoroalkyl indoles. Green oxidation, high regioselectivity, scalable for pharmaceutical intermediates.
Patent CN115286578B reveals metal-free synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.